These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6715032)

  • 21. The effects of sulfhydryl inhibitors and cytochalasin on the cytoplasmic and cytoskeletal actin of human neutrophils.
    Wallace PJ; Packman CH; Wersto RP; Lichtman MA
    J Cell Physiol; 1987 Aug; 132(2):325-30. PubMed ID: 3624318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of polymorphonuclear leukocyte functions by chlortetracycline.
    Elferink JG; Deierkauf M
    Biochem Pharmacol; 1984 Nov; 33(22):3667-73. PubMed ID: 6439210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sodium azide enhances neutrophil migration and exocytosis: involvement of nitric oxide, cyclic GMP and calcium.
    VanUffelen BE; Van der Zee J; de Koster BM; VanSteveninck J; Elferink JG
    Life Sci; 1998; 63(8):645-57. PubMed ID: 9718094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytolytic effect of polylysine on rabbit polymorphonuclear leukocytes.
    Elferink JG
    Inflammation; 1985 Sep; 9(3):321-31. PubMed ID: 4044028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of locomotor activity of polymorphonuclear cells by cationic substances and cationic lysosomal fractions from human neutrophils.
    Nitzan DW; Pruzanski W; Saito S; Ranadive N
    Inflammation; 1985 Dec; 9(4):375-87. PubMed ID: 2416686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exocytotic enzyme release from rabbit polymorphonuclear leukocytes after treatment with fluoride and calcium.
    Elferink JG; Deierkauf M
    Biochim Biophys Acta; 1989 Oct; 1013(3):247-53. PubMed ID: 2508751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneity in chemotaxis of neutrophils with different densities.
    Miyagawa H; Okada C; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1094-9. PubMed ID: 2244894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
    Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
    J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition by phenytoin of chemotactic factor - stimulated neutrophil functions.
    Webster RO; Goldstein IM; Flick MR
    J Lab Clin Med; 1984 Jan; 103(1):22-33. PubMed ID: 6317777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further studies on the structural requirements for synthetic peptide chemoattractants.
    Freer RJ; Day AR; Radding JA; Schiffmann E; Aswanikumar S; Showell HJ; Becker EL
    Biochemistry; 1980 May; 19(11):2404-10. PubMed ID: 7387981
    [No Abstract]   [Full Text] [Related]  

  • 32. Chrysotile asbestos-induced cytotoxicity and calcium-dependent exocytosis in polymorphonuclear leukocytes.
    Elferink JG
    Res Commun Chem Pathol Pharmacol; 1989 Sep; 65(3):361-72. PubMed ID: 2554437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release.
    Becker EL; Showell HJ
    J Immunol; 1974 Jun; 112(6):2055-62. PubMed ID: 4825785
    [No Abstract]   [Full Text] [Related]  

  • 34. Stimulation and inhibition of neutrophil chemotaxis by endothelin-3.
    Elferink JG; de Koster BM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S142-4. PubMed ID: 8587345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-induced activation of neutrophil migration.
    Elferink JG; de Koster BM
    Biochem Pharmacol; 1994 Aug; 48(5):865-71. PubMed ID: 8093098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of microfilament-active drugs, phalloidin and the cytochalasins A and B, on exocytosis in mast cells evoked by 48/80 or A23187.
    Nemeth EF; Douglas WW
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Apr; 302(2):153-63. PubMed ID: 77480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils.
    Elferink JG; De Koster BM
    Biochem Pharmacol; 1995 Sep; 50(7):975-9. PubMed ID: 7575682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production.
    Fantone JC; Marasco WA; Elgas LJ; Ward PA
    Am J Pathol; 1984 Apr; 115(1):9-16. PubMed ID: 6324595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-leukocyte interaction: activation of rabbit platelets by FMLP-stimulated neutrophils.
    Coëffier E; Joseph D; Prévost MC; Vargaftig BB
    Br J Pharmacol; 1987 Oct; 92(2):393-406. PubMed ID: 3118996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of membrane sulfhydryl groups in apomorphine-induced inhibition of neutrophil migration.
    Elferink JG; Deierkauf M
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):187-96. PubMed ID: 3659569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.